Pediatric Inflammatory Multisystem Syndrome;Unusual Presentation of COVID-19 in Children: About Thirty Cases  

作　　者：Fatima-Ezzahra Tahiri Karima El Fakiri Nourredine Rada Ghizlaine Draiss Nadia El Idrissi Slitine Mounir Bourrous Said Younous Mohammed Bouskraoui Fatima-Ezzahra Tahiri;Karima El Fakiri;Nourredine Rada;Ghizlaine Draiss;Nadia El Idrissi Slitine;Mounir Bourrous;Said Younous;Mohammed Bouskraoui(Pediatrics Department A, University Hospital Center Mohamed VI, Marrakech, Morocco;Department of Neonatal Resuscitation, University Hospital Center Mohamed VI, Marrakech, Morocco;Pediatric Emergency Department, University Hospital Center Mohamed VI, Marrakech, Morocco;Pediatric Intensive Care Unit, University Hospital Center Mohamed VI, Marrakech, Morocco)

机构地区：[1]Pediatrics Department A, University Hospital Center Mohamed VI, Marrakech, Morocco [2]Department of Neonatal Resuscitation, University Hospital Center Mohamed VI, Marrakech, Morocco [3]Pediatric Emergency Department, University Hospital Center Mohamed VI, Marrakech, Morocco [4]Pediatric Intensive Care Unit, University Hospital Center Mohamed VI, Marrakech, Morocco

出　　处：《Open Journal of Pediatrics》2023年第1期74-81,共8页儿科学期刊（英文）

摘　　要：Pediatric inflammatory multisystem syndrome PIMS is a new entity of systemic inflammatory disease in children that appeared in the epidemic context of COVID-19 infection in April 2020. The pathophysiological mechanisms of PIMS are poorly understood and the hypothesis of a maladaptive hyperactive immune response, notably involving cytokines, is described in the literature. In our study, we report our experience regarding the clinical presentation, diagnosis, management and outcome of patients who presented with pediatric inflammatory multisystem syndrome post COVID-19.Pediatric inflammatory multisystem syndrome PIMS is a new entity of systemic inflammatory disease in children that appeared in the epidemic context of COVID-19 infection in April 2020. The pathophysiological mechanisms of PIMS are poorly understood and the hypothesis of a maladaptive hyperactive immune response, notably involving cytokines, is described in the literature. In our study, we report our experience regarding the clinical presentation, diagnosis, management and outcome of patients who presented with pediatric inflammatory multisystem syndrome post COVID-19.

关 键 词：COVID-19 Inflammation Kawasaki Like MYOCARDITIS IMMUNOGLOBULINS 

分 类 号：R72[医药卫生—儿科]